helpline 01494 601 400

sodium valproate

Royal Colleges publish new guidance around use of valproate for women and girls of childbearing age with epilepsy

Pregnant woman in a pink dress, cradling her bump

New guidance brings clarity for doctors and patients in applying MHRA regulations around use of sodium valproate for women and girls of childbearing age with epilepsy.

All dosages of Epilim are now back in stock

Various drugs

Sanofi has informed us that all dosages of Epilim (sodium valproate) are now back in stock.

Epilim and Epanutin drug shortages

Epilim and Epanutin

There are currently a supply issues with Epilim Chronosphere (sodium valproate) 250mg Modified Release Granules and Epanutin (phenytoin) oral suspension.

Review into sodium valproate - your chance to have your say

Poster from the review team calling for people to give evidence about sodium valproate. The poster is black and white with some text highlighted in purple

An independent safety review into the epilepsy medication, sodium valproate, is now officially open and has put out a 'call for evidence' from those affected by the drug.

GP practice could close after failure to warn women of risks around sodium valproate

Double fronted two story building that houses Staunton Group Practice. The building is glass fronted.

A GP practice in London could be closed down after inspectors found that staff had failed to warn women of the risks around the epilepsy medication sodium valproate during pregnancy.

Clare Pelham comments on new sodium valproate regulations

Infographic showing a pregnant woman and a girl and asking whether they are taking sodium valproate. The woman is outlined in white and the girl in purple. The foetus is in red as babies exposed to sodium valproate can be at risk

Our CEO Clare Pelham, a member of the Sodium Valproate Expert Working Group, commented on the news of the new regulations surrounding sodium valproate.

Charity tells health secretary new drug regulations could fail without public campaign

Infographic showing a pregnant woman and a girl and asking whether they are taking sodium valproate. The woman is outlined in white and the girl in purple. The foetus is in red as babies exposed to sodium valproate can be at risk

Epilepsy Society today welcomes new regulatory measures to stop babies being born with avoidable disabilities after being exposed to the drug, sodium valproate, in the womb.But the charity cautions that unless the regulations are backed by a public communications campaign, the long-fought-for measures may not reach those women and girls who have no option but to take the drug.

Concerns around sodium valproate

Information about and concerns around the anti-epileptic drug sodium valproate.

Epilepsy Society welcomes new measures to ensure no babies are exposed to sodium valproate during pregnancy

Infographic showing a pregnant woman and a girl and asking whether they are taking sodium valproate. The woman is outlined in white and the girl in purple. The foetus is in red as babies exposed to sodium valproate can be at risk

Epilepsy Society's chief executive Clare Pelham has called today's announcement of new regulatory measures around sodium valproate, 'a landmark moment for all women who have ever been prescribed the epilepsy drug.'

Emma Friedmann and the sodium valproate announcement

Emma Friedmann is a parent carer of her 19 year old son who has fetal valproate syndrome. In February 2018, she attended parliament when the government announced their decision to review handling of concerns around sodium valproate.

 

Pages

Subscribe to RSS - sodium valproate